<DOC>
	<DOCNO>NCT00228982</DOCNO>
	<brief_summary>The purpose study compare clinical cure rate ceftobiprole medocaril versus comparator treatment patient complicate skin skin structure infection .</brief_summary>
	<brief_title>Ceftobiprole Treatment Resistant Staphylococcus Aureus Skin Skin Structure Infections</brief_title>
	<detailed_description>Ceftobiprole medocaril cephalosporin antibiotic anti-MRSA ( Methicillin-Resistant Staphylococcus Aureus ) activity . Ceftobiprole medocaril yet approve treatment complicate skin skin structure infection . This randomized , double-blind , multicenter study ceftobiprole medocaril plus placebo versus comparator ass effectiveness safety ceftobiprole medocaril patient complicate skin skin structure infection . The patient randomize ceftobiprole medocaril plus placebo comparator . The primary endpoint clinical cure rate ceftobiprole medocaril test-of-cure visit . The patient receive either ceftobiprole medocaril plus placebo comparator 7 14 day ( unless extend discretion medical monitor ) .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Staphylococcal Skin Infections</mesh_term>
	<mesh_term>Skin Diseases , Bacterial</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Ceftobiprole</mesh_term>
	<mesh_term>Ceftobiprole medocaril</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Diagnosis infection consistent complicate skin skin structure infection . Known suspect hypersensitivity study medication Any know suspected condition concurrent treatment contraindicate prescribe information Previous enrollment study Treatment investigational drug within 30 day enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Complicated Skin Infections</keyword>
	<keyword>Infectious Skin Diseases</keyword>
	<keyword>Bacterial Skin Diseases</keyword>
	<keyword>Staphylococcal Skin Infections</keyword>
	<keyword>Cephalosporin</keyword>
</DOC>